A patient tells the nurse that he has been using an herbal supplement that contains kava for several years to help him to relax in the evening. However, the nurse notes that he has a yellow tinge to his skin and sclera, and is concerned about liver toxicity. The nurse advises the patient to stop taking the kava and to see his health care provider for an examination. What else, if anything, should the nurse do at this time? a Report this incident to MedWatch. b Notify the state’s pharmaceutical board. c Contact the supplement manufacturer. d No other action is needed.
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here